Skip to main content

Peer Review reports

From: Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study

Original Submission
2 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Mar 2023 Reviewed Reviewer Report
23 Jun 2023 Reviewed Reviewer Report
10 Jul 2023 Author responded Author comments - Xiongwen Yang
Resubmission - Version 3
10 Jul 2023 Submitted Manuscript version 3
23 Jul 2023 Author responded Author comments - Xiongwen Yang
Resubmission - Version 4
23 Jul 2023 Submitted Manuscript version 4
1 Aug 2023 Reviewed Reviewer Report
16 Aug 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
17 Aug 2023 Editorially accepted
30 Aug 2023 Article published 10.1186/s12885-023-11312-4

You can find further information about peer review here.

Back to article page